Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Pantaleo: Poxvirus-Based Vaccine Development |
| Strategy: | Combo: DNA, protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays complete |
| Study Start Date: | 2012-06-20 |
| Study Made Public: | 2016-11-10 |
Title
Evaluation on non-human primates of safety and immunogenicity for priming with NYVAC or DNA +/-gp120, followed by protein boosts in combination with either NYVAC or DNA
Description
CAVD 371 (AUP 512) is a non-human primate study comparing DNA/protein and NYVAC/protein prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
MF59 NYVAC-C-Gag-Pol-Nef NYVAC-C-gp140 DNA-C gp120 C.1086 gp120 TV1Integrated data
BAMA, ICS, NAb
Non-integrated data
No non-integrated data is available for this study.